Cardiac arrhythmia management is entering a new era in which technological innovation, mechanistic understanding, and precision-based therapies are converging to reshape clinical practice. This session is designed to highlight the strategic trajectory of electrophysiology: from the fundamental discoveries that changed the natural history of atrial fibrillation and idiopathic ventricular fibrillation, to the emerging technologies that are redefining the future of ablation.
By bringing together pioneers who generated paradigm shifts and leaders who are shaping next-generation technologies, this session aims to provide not only a scientific update but also a strategic vision for the future of arrhythmia care. The goal is to bridge discovery, innovation, and clinical implementation, supporting a modern electrophysiology that is safer, more reproducible, and increasingly tailored to individual patient profiles.
This session reflects the broader evolution of cardiology toward integrated, technology-enabled, and network-based care models – a key priority for the future of cardiovascular
Moderatori: Antonio Dello Russo (Ancona) – Massimo Grimaldi (Acquaviva delle Fonti)
- 09.00From Pulmonary Veins to Idiopathic Ventricular Fibrillation
Michel Haissaguerre (Bordeaux, Pessac – France) - 09.15Beyond the Veins: Multisite PFA Strategies for Persistent and Long-Standing Persistent AF
Gian Battista Chierchia (Bruxelles) - 09.30PFA Beyond AF: Emerging Roles in Ventricular Arrhythmias
Josef Kautzner (Praga) - 09.45Discussion